Sign in
4

Changes in Ownership

Veradermics, Inc Filed Acc 0001628280-26-060491

Chief R&D Officer acquired 9,650 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hollander David · Chief R&D Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-01 Grant or award : show line 1 in the form +9,650 9,650 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-01 Grant or award : show line 2 in the form Stock Option (Right to Buy) +19,300 19,300 D
Loading xslF345X06/wk-form4_1788467701.xml…